Stay updated on CD123xCD3 DuoBody Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the CD123xCD3 DuoBody Dose Escalation Clinical Trial page.

Latest updates to the CD123xCD3 DuoBody Dose Escalation Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe ClinicalTrials.gov footer now displays site revision v3.8.0 instead of v3.7.2. The study record itself is unchanged.SummaryDifference0.1%

- Check31 days agoChange DetectedAn NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” across NIH content. The site revision identifier is updated from v3.7.1 to v3.7.2.SummaryDifference0.5%

- Check45 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check66 days agoChange DetectedA new revision entry v3.7.0 was added to the record history, and the previous revision v3.6.6 was removed. This indicates the study record was updated to a newer version.SummaryDifference0.1%

- Check80 days agoChange DetectedA new revision entry (v3.6.6) was added to the record history and the previous revision (v3.6.5) was removed, indicating an updated version of the study record.SummaryDifference0.1%

Stay in the know with updates to CD123xCD3 DuoBody Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD123xCD3 DuoBody Dose Escalation Clinical Trial page.